Company & Customers
Where our R&D centers, factories and warehouses are located, and who we serve.
Company Location
CompanyResearch and development centers (RDC), manufacturing bases and warehouses in China, Singapore and the USA. RDC = Research & Development Center.
Shanghai, China
- Enzyme Evolution RDC
- Protein / Antibody RDC
- IVD RDC
- Nucleic acid RDC
- NGS RDC
- 2 manufacture bases
Wuhan, China
- Ultra Clean Factory for Molecular Enzyme
- mRNAtools manufacture base
- Biolink Internet Center
Singapore
- SG Warehouse
USA
- Maryland Business and Warehousing Center
- Overseas R&D Center (under preparation)
Customers
Company20,000+ clients & individual labs across research, clinical, diagnostic and pharmaceutical settings.

images/pcr-ngs/customer-types.jpg
images/pcr-ngs/customer-logos.jpgTechnology Platforms
Six technical platforms and the innovation system behind them – from molecular enzymes and IVD to NGS, mRNA and antibodies.
Technology Platform
OverviewWe have built six technical platforms, and built an innovation system covering the underlying technology and applied technology.
Directed Evolution and Rational Design of Molecular Enzymes Platform
- Rational design of molecular enzymes
- Directed evolution of molecular enzymes based on an ultra-high-throughput single-cell sorting system
High Density Fermentation & Ultra-clean Protein Purification Platform
- Molecular enzyme high-density fermentation technology
- Ultra-clean molecular enzyme production technology (DNA-free, DNase/RNase-free)
Molecular IVD Platform
- 3D-Optimizing of molecular diagnostic reagents
- Freeze-drying technology for diagnostic preparations
NGS Library Preparation Platform
- Enzymatic digestion method for NGS library preparation
- Ultra-fast RNA library construction technology
mRNA Preparation Platform
- mRNA stock solution preparation and analysis technology
- mRNA LNP preparation and evaluation technology
High-quality Monoclonal Antibody Platform
- Hybridoma monoclonal antibody preparation technology
- Phage display technology
- Single B cell antibody preparation technology
Rational Design and Directed Evolution
ZymeEditor™ZymeEditor™ Protein Directed Evolution and Rational Design Platform

images/pcr-ngs/zymeeditor-directed-evolution.jpgHighlights
- Rapid improvement of the key performance of molecular enzymes, including fidelity, activity, sensitivity, specificity, thermostability and substrate binding capacity, to meet application needs.
- Rapid enrichment of beneficial mutation sites, shortening the evolutionary cycle, increasing the success rate of screening and significantly reducing costs.

Molecular Diagnostic Platform
Platform3D-Optimizing of molecular diagnostic reagents and freeze-drying technology for diagnostic preparations.

images/pcr-ngs/freeze-drying-beads.jpgAdvantages
- 3D-Optimizing: to provide our customers with selected enzymes, an optimized reaction buffer and pre-designed primers/probes in compliance with PCR / LAMP technology.
- Freeze-drying: removes more than 97% of the water, with a high success rate of freeze-drying.
- Comprehensive applications: in vitro diagnosis, animal disease, early tumor screening, food safety detection, etc.
NGS Platform
PlatformLibrary preparation technologies for DNA and RNA, supporting applications from basic research to clinical testing.

images/pcr-ngs/ngs-platform.jpgHighlights
- Fast enzymatic digestion method for DNA library preparation
- Ultra-fast RNA library preparation
- Co-library technology that can distinguish between DNA and RNA sources
Advantages
- Short time consumption, high efficiency, high fidelity and high stability
- Applications in tumor diagnosis, genetic disease screening and microbial infection detection (mNGS)
- Supports bioinformatic analysis and data mining
- Compatible with MGI and Illumina sequencers
mRNA Preparation Platform
PlatformPost-transcriptional and co-transcriptional capping routes, from mRNA stock solution to LNP formulation and evaluation.

mRNA stock solution preparation and analysis technology
- mRNA yield can reach 10 g/L, purity can reach more than 90%, and capping rate can reach more than 95%.
- mRNA integrity detection, capping rate detection and Poly(A) tail length detection.
mRNA LNP preparation and evaluation technology
Mastering a series of detection techniques, from in vitro physical characterization and cell-level evaluation to animal-level evaluation.
Hieff Trans™ Advanced R&D Platform
PlatformAI-powered novel transfection reagent development platform – core R&D strengths powered by high-throughput compound library screening.
AI-Driven Molecular Design Platform
- Utilizing AI-based molecular dynamics simulations and high-throughput virtual screening, the platform accurately predicts the structure–function relationships of transfection reagent molecules, rapidly identifying optimal modification sites.
- By simulating interactions between transfection reagents and cell membranes, it optimizes the ratio of cationic density to hydrophobic groups, effectively reducing cytotoxicity while enhancing transfection efficiency.
High-Throughput Biological Validation Platform
- Integrated with automated cell culture and flow cytometry systems, the platform enables high-throughput evaluation of transfection efficiency and cytotoxicity, accelerating the translation of candidate molecules from lab-scale discovery to industrial production.
- Tailored to specific application scenarios, the platform has successfully screened optimal transfection reagents from over ten thousand candidate compounds and completed three successful pilot production batches.

Manufacturing & Quality
Ultra-clean enzyme production, a GMP-grade mRNA raw-material plant and completed DMF filings.
UCF.ME: Ultra Clean Molecular Enzyme Factory
ManufacturingUltra clean enzyme: the molecular enzymes are manufactured through high-density fermentation and an ultra-clean production process, ensuring the cleanliness (DNA/RNA-free, endotoxin-free, sterile, etc.) of enzymes under the ISO 13485 quality management system.

images/pcr-ngs/ucf-me-fermentation.jpgmRNAtools Manufacture Factory
ManufacturingWith an area of more than 5,000 square meters, the plant is equipped with automatic fermentation equipment and industrial-grade purification and freeze-drying facilities.

images/pcr-ngs/mrnatools-factory.jpgDMF Filing
QualityCompleted DMF filing of several products.
Filed products
| S/N | Product name | Application type / number |
|---|---|---|
| 1 | T7 RNA Polymerase | MF037035 |
| 2 | UltraNuclease GMP-grade | MF037298 |
| 3 | mRNA Vaccinia Capping Enzyme GMP-grade | MF037433 |
| 4 | mRNA Cap 2′-O-Methyltransferase GMP-grade | MF037434 |
| 5 | Pyrophosphatase, Inorganic GMP-grade | MF037545 |
| 6 | Murine RNase inhibitor GMP-grade | MF037546 |
| 7 | BspQI GMP-grade | MF037607 |
| 8 | Deoxyribonuclease I (DNaseI) GMP-grade | MF037744 |
| 9 | Salt Active UltraNuclease GMP-grade | MF037815 |
| 10 | PEI Transfection Reagent | MF038217 |
